Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis.

M R Lilien1, M Duran, J M Quak

  • 1Pediatric Renal Centre and Laboratory for Metabolic Diseases, Wilhelmina Children's Hospital, Utrecht, The Netherlands. m.lilien@wkz.azu.nl

Pediatric Nephrology (Berlin, Germany)
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Do we have to remove a painless collar swelling along the carotid artery?].

Laryngo- rhino- otologie·2007
Same author

[Scurvy: an unusual cause of purpura, ecchymosis and arthralgias].

Revista clinica espanola·2007
Same author

High incidence of hypermethioninaemia in a single neonatal intensive care unit detected by a newly introduced neonatal screening programme.

Journal of inherited metabolic disease·2007
Same author

Antimony and heavy metals accumulation in some macroinvertebrates in the Yesilirmak River (N Turkey) near the Sb-mining area.

Bulletin of environmental contamination and toxicology·2007
Same author

[Lactic acidosis and accumulation of glutamate in the blood of neonates following treatment with calcium levulinate for hypocalcaemia].

Nederlands tijdschrift voor geneeskunde·2007
Same author

Renal Fanconi syndrome with ultrastructural defects in lysinuric protein intolerance.

Journal of inherited metabolic disease·2007
Same journal

Chronic hyponatraemia with a reset osmostat: when abnormal is normal.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Clinical value of repeat kidney biopsy in pediatric IgA vasculitis nephritis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

The European Society of Pediatric Nephrology Board Examination-a certified benchmark of knowledge and clinical practice with global recognition.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

A rare but misleading cause of hematuria in hemophilia A: renal pelvic hemorrhage mimicking tumor.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Diastolic echocardiographic parameters identify pediatric kidney transplant recipients with structural myocardial alterations.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Pediatric clinician perspectives on clinical decision support tools for chronic kidney disease risk after preterm birth.

Pediatric nephrology (Berlin, Germany)·2026
See all related articles

L-carnitine supplementation did not reduce the need for recombinant human erythropoietin (rhEPO) in children with chronic kidney disease on dialysis. This study found no significant changes in rhEPO requirements or hemoglobin levels.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Nutritional Science

Background:

  • Recombinant human erythropoietin (rhEPO) treats anemia in pediatric chronic renal failure but is costly.
  • L-carnitine supplementation may reduce rhEPO needs in adults with anemia.

Purpose of the Study:

  • To evaluate the impact of oral L-carnitine on rhEPO requirements in children undergoing dialysis.
  • To assess changes in hematological parameters with L-carnitine supplementation.

Main Methods:

  • A prospective study involving 16 children on hemodialysis or peritoneal dialysis.
  • Children received L-carnitine (20 mg/kg/day) for 26 weeks, with baseline and follow-up data collection.
  • Measured rhEPO requirements, hemoglobin, hematocrit, and carnitine levels.

Related Experiment Videos

Main Results:

  • L-carnitine supplementation significantly increased free and total carnitine levels (P<0.05).
  • No significant reduction in rhEPO requirement was observed.
  • Hemoglobin and hematocrit levels remained unchanged throughout the study.

Conclusions:

  • Oral L-carnitine supplementation did not demonstrate a beneficial effect on rhEPO requirement in pediatric dialysis patients.
  • Further research may be needed to explore L-carnitine's role in pediatric anemia management in renal failure.